Which condition is associated with an inability to process mucopolysaccharides?

Hunter Syndrome, also known as mucopolysaccharidosis type II, is a genetic disorder caused by a deficiency in the enzyme iduronate-2-sulfatase. This enzyme is crucial for the breakdown of mucopolysaccharides, which are long chains of sugar molecules used in the body to build connective tissues, such as cartilage and skin.

Individuals with Hunter Syndrome cannot effectively process mucopolysaccharides, leading to their accumulation in various tissues. This can result in a range of symptoms, including physical deformities, cognitive impairment, and cardiovascular issues. The lack of proper enzymatic function in this condition highlights the significance of mucopolysaccharide metabolism in maintaining the health of connective tissue and overall bodily function. Understanding disorders like Hunter Syndrome is crucial for early diagnosis and intervention, which can significantly impact the quality of life of those affected.